Relevance of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy

被引:31
|
作者
Kasama, Tsuyoshi [1 ]
Wakabayashi, Kuninobu [1 ]
Sato, Michihito [1 ]
Takahashi, Ryo [1 ]
Isozaki, Takeo [1 ]
机构
[1] Showa Univ, Sch Med, Dept Med, Div Rheumatol,Shinagawa Ku, Tokyo 1428666, Japan
关键词
FRACTALKINE RECEPTOR CX(3)CR1; CX3C CHEMOKINE FRACTALKINE; WEGENERS-GRANULOMATOSIS; RHEUMATOID-ARTHRITIS; TNF-ALPHA; CHLAMYDIA-PNEUMONIAE; SYSTEMIC VASCULITIS; LEUKOCYTE MIGRATION; SOLUBLE FRACTALKINE; ENDOTHELIAL-CELLS;
D O I
10.1016/j.trsl.2009.08.009
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The clinical presentation of systemic vasculitis can vary widely and include skin disorders, neuropathy, eye symptoms, and systemic inflammation. The precise molecular mechanisms underlying this syndrome are not fully understood, but the importance of a chronic imbalance of the cytokines and chemokines involved in orchestrating inflammatory responses is now recognized. In similar fashion, atherosclerosis is now recognized to be a chronic inflammatory disease in which chemokines play important roles. In the current review, we discuss the involvement of CX3CL1, which is a unique member of the chemokine family, and its receptor, CX3CR1, in the pathogenesis of these vasculopathies. (Translational Research 2010;155:20-26)
引用
收藏
页码:20 / 26
页数:7
相关论文
共 50 条
  • [1] Therapeutic intervention of inflammatory/ immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway
    Imai T.
    Yasuda N.
    [J]. Inflammation and Regeneration, 36 (1)
  • [2] Role of fractalkine/CX3CL1 and its receptor CX3CR1 in allergic diseases
    Julia, Valerie
    Staumont-Salle, Delphine
    Dombrowicz, David
    [J]. M S-MEDECINE SCIENCES, 2016, 32 (03): : 260 - 266
  • [3] Fractalkine/CX3CL1 in Neoplastic Processes
    Korbecki, Jan
    Siminska, Donata
    Kojder, Klaudyna
    Grochans, Szymon
    Gutowska, Izabela
    Chlubek, Dariusz
    Baranowska-Bosiacka, Irena
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [4] Fractalkine/CX3CL1 in rheumatoid arthritis
    Nanki, Toshihiro
    Imai, Toshio
    Kawai, Shinichi
    [J]. MODERN RHEUMATOLOGY, 2017, 27 (03) : 392 - 397
  • [5] Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
    Stavros Apostolakis
    Demetrios Spandidos
    [J]. Acta Pharmacologica Sinica, 2013, 34 : 1251 - 1256
  • [6] Fractalkine-CX3CR1与肺疾病
    向永红
    张云
    苏晓丽
    胡成平
    [J]. 国际呼吸杂志, 2011, (22) : 1755 - 1760
  • [7] Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
    Apostolakis, Stavros
    Spandidos, Demetrios
    [J]. ACTA PHARMACOLOGICA SINICA, 2013, 34 (10) : 1251 - 1256
  • [8] Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease
    Patel, A.
    Jagadesham, V. P.
    Porter, K. E.
    Scott, D. J. A.
    Carding, S. R.
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2008, 36 (01) : 20 - 27
  • [9] Expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the trigeminal ganglia: implications for craniofacial nociception
    Gazerani, P.
    Cairns, B. E.
    Dong, X. D.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [10] Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis
    Hasegawa, M
    Sato, S
    Echigo, T
    Hamaguchi, Y
    Yasui, M
    Takehara, K
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (01) : 21 - 28